Earnings for Nov. 10, 2020

La Jolla Pharmaceutical Co., of San Diego, reported third-quarter revenue of $9.1 million, including $7.2 million in sales of Giapreza (angiotensin II), …

Read More
  • You already voted!
  • Read More